NMIN

PEOPLE

NMIN leverages the research and entrepreneurial excellence of a pan-Canadian, multidisciplinary team.

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals. The BoD receives input from two Advisory Committees: the Executive & Nominating Committee, and the Finance & Audit Committee.

NMIN’s Management Team consists of the Scientific Director & CEO, the Associate Scientific Director, and the Executive Director.

NMIN’s Research program receives oversight and strategic direction from the Research Management Committee (RMC). Each of the program’s three Themes and two Core Facilities are further overseen by two Co-leaders.

The RMC receives input from three committees: the KTEE Advisory Committee, the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

The Administrative Centre Team provides support to the Research and the HQP programs, and implements the network’s administration, operations, IP, and communications cores on a day-to-day basis.

NMIN

PEOPLE

NMIN leverages the research and entrepreneurial excellence of a pan-Canadian, multidisciplinary team.

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals. The BoD receives input from two Advisory Committees: the Executive & Nominating Committee, and the Finance & Audit Committee.

NMIN’s Management Team consists of the Scientific Director & CEO, the Associate Scientific Director, and the Executive Director.

NMIN’s Research program receives oversight and strategic direction from the Research Management Committee (RMC). Each of the program’s three Themes and two Core Facilities are further overseen by two Co-leaders.

The RMC receives input from three bodies: the Commercialization Advisory Board (CAB), the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

The Administrative Centre Team provides support to the Research and the HQP programs, and implements the network’s administration, operations, IP, and communications cores on a day-to-day basis.

NMIN

GOVERNANCE

Board of Directors

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals.

The BoD includes 10 individuals with leadership experience in areas ranging from law to corporate management. Committees of the Board include the Board Executive, Board Nomination, Audit and Finance, Conflict of Interest, and Ethics Advisory committees. Members of the BoD also form adhoc committees or special task forces as needed.

CHAIR: Don Enns

President & CEO, Day1Ventures

Christine Allen

Associate Vice-President & Vice-Provost, Strategic Initiatives, University of Toronto; Scientific Director & CEO, NMIN

Michael Coughtrie

Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis

Professor, Department of Biochemistry and Molecular Biology, UBC

CHAIR: Don Enns

President & CEO, Day1Ventures

Christine Allen

Associate Vice-President & Vice-Provost, Strategic Initiatives, University of Toronto; Scientific Director & CEO, NMIN

Lesley Esford

Board Director, Innovate BC

Rachel Fernandez

Associate Vice-President, Research & Innovation, University of British Columbia

Vanessa Grant

Partner, Norton Rose Fulbright Canada LLP

Inès Holzbaur

Co-Founder & Managing Partner, AmorChem

David Martin

Managing Director & Head of Equity Research, Bloom Burton & Co

Norma Sebestyen

Advisor, Health Innovation, Strategy and Commercialization

Michael Coughtrie

Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis

Professor, Department of Biochemistry & Molecular Biology

Lesley Esford

Board Director, Innovate BC

Rachel Fernandez

Associate Vice-President, Research & Innovation, University of British Columbia

Vanessa Grant

Partner, Norton Rose Fulbright Canada LLP

Inès Holzbaur

Co-Founder & Managing Partner, AmorChem

David Martin

Managing Director & Head of Equity Research, Bloom Burton & Co

Norma Sebestyen

Advisor, Health Innovation, Strategy and Commercialization

Rebecca Yu

Vice President, Market Access and External Affairs, Takeda Canada

NMIN

NETWORK MANAGEMENT

Management Team

NMIN’s Scientific Leadership Team is comprised of the Scientific Director, the Associate Scientific Director, and the Executive Director, who provide strategic leadership and overall management.

Pieter Cullis

Scientific Director & CEO

Christine Allen

Scientific Director & CEO

Gilbert Walker

Associate Scientific Director

Diana Royce

Executive Director

Pieter Cullis

Scientific Director & CEO

Christine Allen

Scientific Director & CEO

Gilbert Walker

Associate Scientific Director

Diana Royce

Executive Director

NMIN

research MANAGEMENT

Research Management Committee

With representatives from academic and industry partners, the Research Management Committee (RMC) is responsible for ongoing assessment of all projects and provides recommendations to the BoD regarding research priorities and budget allocations.

The RMC receives input from three committees: the Commercialization Advisory Board (CAB), the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

CHAIR: Terry M Allen

Professor Emerita, Pharmacology & Oncology, University of Alberta and Visiting Professor, Biochemistry & Molecular Medicine, University of British Columbia

Christine Allen

Scientific Director & CEO, NMIN
University of Toronto

Marcel Bally

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Warren Chan

Theme 3 Co-leader
University of Toronto

CHAIR: Terry M Allen

Professor Emerita, Pharmacology & Oncology, University of Alberta and Visiting Professor, Biochemistry & Molecular Medicine, University of British Columbia

Christine Allen

Scientific Director & CEO, NMIN
University of Toronto

Marcel Bally

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Warren Chan

Theme 3 Co-leader
University of Toronto

Connie Chen

Senior Director, Strategy & Corporate Development
FACIT

Pieter Cullis

Theme 2 & NanoCore Co-Leader
University of British Columbia

Emmanuel Ho

Associate Professor
University of Waterloo

Christian Kastrup

Theme 2 & NanoCore Co-Leader
University of British Columbia

Connie Chen

Senior Director, Strategy & Corporate Development
FACIT

Pieter Cullis

Theme 2 & NanoCore Co-Leader
University of British Columbia

Emmanuel Ho

Associate Professor
University of Waterloo

Christian Kastrup

Theme 2 & NanoCore Co-Leader
University of British Columbia

Shana Kelley

Theme 3 Leader
University of Toronto

Shyh-Dar (Star) Li

Theme 1 & PharmaCore Co-Leader
University of British Columbia

David Martin

Board Representative
NMIN Board Member

Norbert Maurer

External
Evonik Transferra

Parimal Nathwani

President and CEO, TIAP
MaRS Innovation

Shyh-Dar (Star) Li

Theme 1 & PharmaCore Co-Leader
University of British Columbia

David Martin

Board Representative
NMIN Board Member

Parimal Nathwani

President and CEO
TIAP

Gilbert Walker

Theme 3 Co-Leader & Associate Scientific Director
University of Toronto

David O’Neill

External
FACIT

Gilbert Walker

Theme 3 Co-Leader & Associate Scientific Director
University of Toronto

Kaley Wilson

Director, Business Development
Quark Venture

Karen Chan

Observer
NanoCore Operational Lead

Kaley Wilson

Director, Business Development
Quark Venture

Karen Chan

Observer
NanoCore Operational Lead

Nancy Dos Santos

Observer
PharmaCore Operational Lead

Sara Esam

Observer
NCE Secretariat

Mark Pereira

Observer
Theme 3 Research & KTEE Accelerator

Sams Sadat

Observer
NHN Vice-President

Mark Pereira

Observer
Theme 3 Research & KTEE Accelerator

Valentina Francia

Observer
Theme 2 Research & KTEE Accelerator

Nancy Dos Santos

Observer
PharmaCore Operational Lead

Valentina Francia

Observer
Theme 2 Research & KTEE Accelerator

Sara Esam

Observer
NCE Secretariat

Mark Pereira

Observer
Theme 3 Research & KTEE Accelerator

Sams Sadat

Observer
NHN Vice-President

Research Theme & Core Facilities Leaders

NMIN research is organized into three themes, led by Theme Leaders: Targeted Drug Delivery, Gene Therapy, and Diagnostics, each consisting of up to 10 projects. The research themes are supported by two core facilities led by Core Leaders: NanoCore and PharmaCore

Theme 1: Targeted Drug Delivery

Theme 2: Gene Therapy

Marcel Bally

Theme Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Theme Co-Leader
University of British Columbia

Pieter Cullis

Theme Co-Leader
University of British Columbia

Christian Kastrup

Theme Co-Leader
University of British Columbia

Theme 1: Targeted Drug Delivery

Marcel Bally

Theme Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Theme Co-Leader
University of British Columbia

Theme 2: Gene Therapy

Pieter Cullis

Theme Co-Leader
University of British Columbia

Christian Kastrup

Theme Co-Leader
University of British Columbia

Theme 3: Diagnostics

HQP Program

Warren Chan

Theme Co-Leader
University of Toronto

Gilbert Walker

Theme Co-Leader & Associate Scientific Director
University of Toronto

Mark Pereira

Theme Accelerator
University of Toronto

Christine Allen

HQP & Capacity Building Leader & Associate Scientific Director
University of Toronto

Theme 3: Diagnostics

HQP Program

Warren Chan

Theme Co-Leader
University of Toronto

Gilbert Walker

Theme Co-Leader & Associate Scientific Director
University of Toronto

Mark Pereira

Theme Accelerator
University of Toronto

NanoCore

PharmaCore

Pieter Cullis

Core Co-Leader
University of British Columbia

Christian Kastrup

Core Co-Leader
University of British Columbia

Karen Chan

Core Operational Lead
University of British Columbia

Marcel Bally

Core Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Core Co-Leader
University of British Columbia

Nancy Dos Santos

Core Operational Lead
BC Cancer Agency

NanoCore

Pieter Cullis

Core Co-Leader
University of British Columbia

Christian Kastrup

Core Co-Leader
University of British Columbia

Karen Chan

NanoCore Operational Lead
University of British Columbia

PharmaCore

Marcel Bally

Core Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Core Co-Leader
University of British Columbia

Nancy Dos Santos

Core Operational Lead
BC Cancer Agency

NMIN

administration

Administrative Centre Team

The Administrative Centre team consists of the Executive Director, the Executive Assistant, the Finance Manager, the Research and Partnerships Manager, the HQP & Events Coordinator, and the Digital Initiatives Consultant. This team supports and facilitates the work of the network’s Governance, Management and Program teams, and is responsible for the network’s day-to-day operations.

Diana Royce

Executive Director

dianaroyce@nanomedicines.ca


Diana Royce

Executive Director

dianaroyce@nanomedicines.ca


Marion Athané

Executive Assistant

email

Marshall Beck

Digital Initiatives / Communications Manager

email

Research

email

Leah Graystone

HQP & Events Coordinator

email

Diana Royce

Executive Director

dianaroyce@nanomedicines.ca

Maria Barros

Executive Assistant

mariabarros@nanomedicines.ca

Marshall Beck

Digital Initiatives Consultant

mbeck@nanomedicines.ca

Leah Graystone

HQP & Events Coordinator

leahgraystone@nanomedicines.ca

Andrew Kim

Accountant

andrewkim@nanomedicines.ca

Daniel Rogers

Manager, Research & Partnerships

danrogers@nanomedicines.ca

NMIN

CONTACT

NMIN

2350 Health Sciences Mall, Room 5451

University of British Columbia

Vancouver, BC V6T 1Z3

Canada

info@nanomedicines.ca